niacinamide and alpha-synuclein

niacinamide has been researched along with alpha-synuclein in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Feng, Z; Gao, H; Jia, H; Jia, X; Li, X; Liu, J; Zhang, H; Zhao, L1
Barrientos, A; Liu, J; Ocampo, A1
Ai, T; Chen, L; More, SS; Wilson, DJ; Xie, J1
Willyard, C1

Other Studies

4 other study(ies) available for niacinamide and alpha-synuclein

ArticleYear
High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease.
    Journal of neuroscience research, 2008, Volume: 86, Issue:9

    Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Cell Line, Tumor; Cell Survival; Disease Models, Animal; DNA Damage; DNA, Mitochondrial; Drosophila; Humans; Ketoglutarate Dehydrogenase Complex; Mitochondria; Motor Activity; Neuroblastoma; Niacinamide; Oxidative Phosphorylation; Parkinsonian Disorders

2008
NAD+ salvage pathway proteins suppress proteotoxicity in yeast models of neurodegeneration by promoting the clearance of misfolded/oligomerized proteins.
    Human molecular genetics, 2013, May-01, Volume: 22, Issue:9

    Topics: alpha-Synuclein; Gene Expression; Histone Deacetylases; Mitochondria; NAD; Niacinamide; Nicotinamide-Nucleotide Adenylyltransferase; Oxidative Phosphorylation; Peptides; Protein Folding; Saccharomyces cerevisiae; Wallerian Degeneration

2013
5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors.
    Journal of medicinal chemistry, 2016, Apr-14, Volume: 59, Issue:7

    Topics: alpha-Synuclein; Animals; Chemistry Techniques, Synthetic; Dogs; Drug Stability; Humans; Kinetics; Madin Darby Canine Kidney Cells; Mice; Microsomes, Liver; Niacinamide; Sirtuin 2; Sirtuins; Structure-Activity Relationship

2016
How gut microbes could drive brain disorders.
    Nature, 2021, Volume: 590, Issue:7844

    Topics: alpha-Synuclein; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Autism Spectrum Disorder; Bacterial Proteins; Clinical Trials as Topic; Depression; Female; Gastrointestinal Microbiome; Humans; Interleukin-17; Limosilactobacillus reuteri; Mice; Niacinamide; Parkinson Disease; Pregnancy; Stroke; Th17 Cells; Vagus Nerve

2021